Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

Published:2016-07-14 Issue:4 Volume:115 Page:411-419
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Okuma H S,Koizumi F,Hirakawa A,Nakatochi M,Komori O,Hashimoto J,Kodaira M,Yunokawa M,Yamamoto H,Yonemori K,Shimizu C,Fujiwara Y,Tamura K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016184.pdf

Reference62 articles.

1. Ahdesmaki M, Lancashire L, Proutski V, Wilson C, Davison TS, Harkin DP, Kennedy RD (2013) Model selection for prognostic time-to-event gene signature discovery with applications in early breast cancer data. Stat Appl Genet Mol Biol 12: 619–635.

2. Ando M, Yamauchi H, Aogi K, Shimizu S, Iwata H, Masuda N, Yamamoto N, Inoue K, Ohono S, Kuroi K, Hamano T, Sukigara T, Fujiwara Y (2014) Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression. Breast Cancer Res Treat 145: 401–409.

3. Andre F, Mazouni C, Liedtke C, Kau SW, Frye D, Green M, Gonzalez-Angulo AM, Symmans WF, Hortobagyi GN, Pusztai L (2008) HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer. Breast Cancer Res Treat 108: 183–190.

4. Barnhart BC, Lee JC, Alappat EC, Peter ME (2003) The death effector domain protein family. Oncogene 22: 8634–8644.

5. Blobel CP (2005) ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32–43.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial;iScience;2024-08

2. Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis;Current Medical Research and Opinion;2024-04-10

3. Construction and analysis of pseudogene-related ceRNA network in breast cancer;Scientific Reports;2023-12-10

4. Theranostic Interpolation of Genomic Instability in Breast Cancer;International Journal of Molecular Sciences;2022-02-07

5. DNA Chip;Encyclopedia of Gerontology and Population Aging;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3